Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Himalaya Wealth launches ₹500 crore SME fund to back manufacturing, deeptech firms
The Category I AIF will target profitable growth-stage SMEs in sectors including aerospace, defence, industrial automation and healthcare, amid rising investor interest in manufacturing-led businesses.

Stocks to Watch for May 27: Coal India, JK Tyre, Siemens, HG Infra and more
JK Tyre leads Q4 earnings as profits surge, while P&G Health, Siemens, Fino Payments Bank and others post mixed results and key dividend, leadership updates. Here are few stocks to track ahead of Wednesday's session.

AstraZeneca Pharma India Q4 profit drops 23% despite strong revenue growth
Oncology, biopharma growth drive FY26 performance; board recommends ₹36/share dividend

Morepen Laboratories Q4 net profit tanks despite higher revenue; declares ₹0.20 dividend
Shares of Morepen Laboratories Ltd ended at ₹44.10, up by ₹0.36, or 0.82%, on the BSE.

P&G Health Q4 profit soars 55% on strong EBITDA, margins; declares ₹45 final dividend
The board recommended a final dividend of ₹45 per equity share for FY26. Including the interim and special dividend declared earlier in the year, the total dividend payout for FY26 stands at ₹205 per share. Shares of the company ended 1.12% lower at ₹5,662, ahead of the Q4 earnings result announcement on Tuesday, May 26.

Bharti, Vodafone Idea tower additions will take Indus Towers shares higher by 32%, CLSA says
With the company's high free cash flow, its dividend payouts should continue and its yields also have an upside, according to CLSA, who went on to add that at 6 times its Enterprise Value to EBITDA, the valuations of Indus Towers are cheap.

Poly Medicure shares slide 5% after Q4 net profit drops 28%; declares ₹3.5 dividend
The company’s board recommended a dividend of ₹3.5 per equity share of face value ₹5 each for FY26, subject to shareholders’ approval. Shares of Poly Medicure Ltd ended at ₹1,518.00, down by ₹80.75, or 5.05%, on the BSE.
Narayana Hrudayalaya jumps 6% after Q4FY26 results, dividend announcement
For the January to March quarter of FY26, Narayana Hrudayalaya delivered record revenue and profit growth, driven by strong operational performance across geographies.

Divi's Laboratories Q4 profit rises 13%, beating estimates; margin slips
The board of the Hyderabad-based pharmaceutical company also recommended a final dividend of ₹30 per share for FY26.
Divi's Laboratories Q4 Results: Cons PAT grows 13% YoY to Rs 751 crore, revenue up 10%; Rs 30 per share dividend announced
Divi's Laboratories Q4 Results: Divi's Laboratories announced strong financial results for the March quarter. Net profit rose 13% to Rs 751 crore. Revenue from operations increased 10% to Rs 2,831 crore. The company recommended a final dividend of Rs 30 per equity share for FY26. Full-year profit after tax stood at Rs 2,568 crore.

Cotec Healthcare, Deepa Jewellers receive SEBI's nod to float IPOs
Cotec Healthcare and Deepa Jewellers get SEBI approval for IPOs, plan fresh issues and OFS to fund capacity expansion, working capital and general corporate needs, to list on BSE and NSE

Fortis Healthcare Q4 profit up 45% on lower exceptional losses, higher revenue
The board recommended a final dividend of ₹1 per equity share of face value ₹10 each for FY26. Shares of Fortis Healthcare Limited ended ₹5.40 lower at ₹961.90 on the NSE today, May 22.